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Exhaled breath temperature (EBT) is a biomarker of inflammation and vascularity of the airways already shown to predict 
incident COPD. This cross-sectional study was aimed to assess the potential of EBT in identifying “healthy” smokers 
susceptible to cigarette smoke toxicity of the airways and to the risk of developing COPD by analysing the dynamics of 
EBT after smoking a cigarette and its associations with their demographics (age, smoking burden) and lung function. The 
study included 55 current smokers of both sexes, 29–62 years of age, with median smoking exposure of 15 (10–71.8) 
pack-years. EBT was measured at baseline and 5, 15, 30, 45, and 60 min after smoking a single cigarette. Lung function 
was measured with spirometry followed by a bronchodilator test. To compare changes in EBT between repeated 
measurements we used the analysis of variance and the area under the curve (EBT
AUC
) as a dependent variable. Multivariate 
regression analysis was used to look for associations with patient characteristics and lung function in particular. The 
average (±SD) baseline EBT was 33.42±1.50 °C. The highest significant increase to 33.84 (1.25) °C was recorded 5 min 
after the cigarette was smoked (p=0.003), and it took one hour for it to return to the baseline. EBT
AUC
 showed significant 
repeatability (ICC=0.85, p<0.001) and was significantly associated with age, body mass index, number of cigarettes 
smoked a day, baseline EBT, and baseline FEF75 (R
2=0.39, p<0.001 for the model). Our results suggest that EBT after 
smoking a single cigarette could be used as early risk predictor of changes associated with chronic cigarette smoke 
exposure.
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New estimates predict that by 2020 chronic obstructive 
pulmonary disease (COPD) will become the third leading 
cause of death worldwide (1). Its major aetiopathogenic 
feature – the damage of the small airways (small airway 
dysfunction) – is present from the early stages of COPD 
and becomes more prominent as the disease progresses (2). 
However, current tests of small airway function have not 
been widely accepted for routine use in the early stages of 
the disease because their results vary significantly, there are 
no validated reference ranges, CT scans follow complex 
protocols, and/or because they cost a lot. Diagnosing COPD 
in later stages, however, means that the lungs have already 
been severely damaged. It is therefore essential to find a 
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new, possibly non-invasive early-stage diagnostic method 
to prevent the development of the disease. One of the 
methods showing potential in that respect is exhaled breath 
temperature (EBT) measurement. It has recently been 
introduced as a new, non-invasive marker of inflammation 
of the respiratory tract in patients with respiratory diseases 
(asthma, COPD, cystic fibrosis, bronchial carcinoma), as it 
was consistently and significantly higher than in healthy 
controls (3, 4). As a biomarker of inflammation and 
vascularity of the airways it can be used alone or in 
combination with other inflammatory biomarkers like 
leukocyte and eosinophil counts, exhaled nitric oxide 
(FeNO), C-reactive protein, and club cell secretory protein 
(3, 4).
Airway sensitivity to cigarette smoke is somewhat 
specific in COPD, as less than 30 % of smokers develop 
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COPD during their lifetime. Our recent cohort research (4) 
showed that an increase in EBT five minutes after smoking 
a single cigarette could be moderately predictive of incident 
COPD in smokers over two years of follow-up. What that 
study missed to investigate was the dynamics of EBT after 
a single smoked cigarette and how this dynamics relates to 
chronic cigarette smoke exposure and lung function, small 
airway dysfunction in particular, as an early marker of future 
COPD. Therefore, the aim of this study was to assess the 
potential of the dynamics of EBT after smoking a single 
cigarette in identifying smokers prone to COPD by 
associating it with lung function (small airway dysfunction) 
and demographics (age, sex, smoking burden).
PARTICIPANTS AND METHODS
Participants and study design
This cross-sectional study included a group of 55 current 
smokers: 43 women and 12 men, 29–62 years of age, whose 
median smoking exposure was 15 pack-years (Table 1). It 
was a sub-study of the MARKO project published elsewhere 
(5). None of the participants had a history of chronic 
respiratory disorders or cardiovascular or other significant 
systemic diseases. The testing was conducted at least four 
weeks after an acute respiratory episode and participants 
were instructed to restrain from smoking, eating, drinking, 
and taking any medicines at least two hours before and 
during the testing.
The diagnostic workup included medical history, 
physical examination, baseline EBT, and EBT at 5, 15, 30, 
45, and 60 min after having smoked a cigarette, and lung 
function measurements followed by a bronchodilator test. 
In a random subsample of 12 participants EBT measurements 
were repeated at the same time on another day to test the 
repeatability of EBT dynamics. The study was conducted 
in accordance with the ethical principles of the Declaration 
of Helsinki and was approved by the ethics committees of 
the Srebrnjak Children’s Hospital (No. 4/2010) and the 
University Hospital Center Osijek (No. 25-1:10359-
4/2014). All patients provided written informed consent.
Lung function
Lung function was measured with spirometry using a 
computerised pneumotachgraph (Jaeger®, CareFusion, 
Yorba Linda, CA, USA) according to the ATS/ERS 
guidelines (6), and the record included the best of three 
technically satisfactory attempts. The bronchodilator test 
was done by repeating spirometry 20 min after salbutamol 
(400 µg) inhalation using an inhalation chamber. Spirometric 
indices – forced vital capacity (FVC), forced expiratory 
volume in one second (FEV1), FEV1/FVC ratio, peak 
expiratory flow (PEF), and forced expiratory flow at 75 % 
of FVC (FEF75) – were recorded as absolute values, 
percentages of the predicted values, percentiles, and 
z-scores according to Quanjer (7, 8).
Exhaled breath temperature
EBT was measured using an X-Halo® device (Delmedica 
Investments, Singapore) according to a previously validated 
method (9, 10). We measured multiple expirations, with the 
device signalling the end of measurement when EBT 
reached thermal equilibrium. Details about the measurement 
have been described elsewhere (3). In short, patients inhaled 
through the nose and exhaled into the device in a tidal 
breathing pattern through the mouth. Room temperature 
was 22–25°C and relative humidity 30–60 %. According 
to Popov et al. (10), measurement precision is 0.01 °C and 
reproducibility 0.99 (intra-class correlation coefficient).
Data analysis
For statistical analysis we used STATISTICA version 
12 (StatSoft, Inc., Tulsa, OK, USA). The minimal sample 
size of 39 for multivariate analysis of up to five independent 
variables was calculated using the expected R-squared of 
0.36, statistical power of 90 %, and alpha of 0.05. Numerical 
data are expressed as means and standard deviations (SD) 
or as medians and interquartile ranges, depending on the 
type of distribution. Normality of distribution was tested 
with the Kolmogorov-Smirnov test. Categorical data are 
expressed as frequency and proportion (%). Numerical data 
Table 1 Baseline characteristics of the participants (n=55)
Mean SD Range
Age (years) 41.8 9.2 28.5 61.9
Women (%)* 43 (78.2)
BMI (kg/m2) 24.54 4.09 17.53 33.46
Smoking (years) 20.7 8.8 6.0 42.0
Cigarettes per day 15.9 7.7 5 35
Cigarette smoking (pack-years)** 15 (7-24) 10.0 71.8
Systolic blood pressure (mmHg) 123 10 110 150
Diastolic blood pressure (mmHg) 76 8 60 100
Hearth rate per minute 71 8 58 91
* results expressed as frequency (%). ** results expressed as median (interquartile range). SD – standard deviation; BMI – body mass 
index
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not following normal distribution were normalised. 
Repeated measurements of EBT changes from baseline 
were tested with the analysis of variance (ANOVA). EBT 
changes from baseline until minute 60 were also calculated 
as the area under the curve [EBT
AUC
, expressed in 
°C*minutes (°Cmin)] for each participant and analysed as a 
dependent variable. The repeatability of EBT
AUC
 was tested 
using concordance correlation in a group of 12 participants 
and expressed as an intra-class correlation coefficient (ICC). 
The group was also divided into two subgroups regarding 
the EBT
AUC
 (increase vs. decrease in EBT). The two 
subgroups were compared using Student’s t-test. The 
association between EBT
AUC
 and independent variables was 
assessed with univariate and multivariate regression 
analysis. Independent variables showing an association with 
EBT
AUC
 of p<0.10 were used for a multivariate regression 
model using a stepwise approach. The final regression 
model was checked against significantly associated 
variables with variance inflation factor checked. P<0.05 
was considered statistically significant for all tests, corrected 
for multiple comparisons.
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RESULTS
Table 2 shows lung function measurements in all 
participants. At baseline, mean EBT of all participants was 
33.42±1.50 °C, then rose to its highest 33.84±1.25 °C 5 min 
after the smoked cigarette (p=0.003), and dropped back to 
33.51 (1.53) °C (p=0.999, Table 3) 60 min after the smoked 
cigarette. This pattern, expressed as area under the curve 
(EBT
AUC
), showed significant repeatability (ICC=0.85, 
p<0.001).
The participants, however, exhibited two distinct 
patterns: 37 had an increase in EBT after having smoked a 
cigarette, and 18 had a decrease (EBC
AUC
 was significantly 
different, p<0.001, Table 3), even though these two groups 
did not differ in baseline characteristics or lung function 
parameters (p>0.05 for all). 
In univariate analysis, EBT
AUC
 was significantly 
associated with baseline EBT, baseline and post-
bronchodilator FEV1/FVC (expressed as absolute values, 
z-scores and percentiles), baseline FEV1 (expressed as z-score 
and % predicted), post-bronchodilator FEV1 (% predicted), 
Table 2 Baseline and post-bronchodilator lung function parameters (n=55)






FVC (% predicted) 96.20 8.19 76.10 113.30
FVC (percentile) 40.12 21.05 2.45 81.41
FVC (z-score) -0.30 0.65 -1.97 0.89
FEV1 (% predicted) 98.43 11.70 75.82 128.97
FEV1 (percentile) 45.51 27.97 3.76 98.33
FEV1 (z-score) -0.12 0.93 -1.78 2.13
FEV1/FVC 0.83 0.07 0.67 0.95
FEV1/FVC (percentile) 57.06 29.43 2.75 98.25
FEV1/FVC (z-score) 0.30 1.11 -1.92 3.30
FEF75 (percentile) 60.93 25.62 19.47 99.13











FVC (% predicted) 97.89 8.33 80.87 114.11
FVC (percentile) 44.42 22.34 5.85 87.43
FVC (z-score) -0.17 0.66 -1.57 1.15
FEV1 (% predicted) 102.22 10.15 80.05 128.14
FEV1 (percentile) 55.13 24.97 7.04 97.82
FEV1 (z-score) 0.18 0.80 -1.47 2.02
FEV1 change (%) 4.16 4.69 -4.77 15.16
FEV1/FVC 0.85 0.06 0.71 0.95
FEV1/FVC (percentile) 65.61 26.97 9.89 98.27
FEV1/FVC (z-score) 0.60 1.02 -1.29 3.20
FEF75 (percentile) 69.84 20.70 23.10 98.84
FEF75 (z-score) 0.67 0.75 -0.74 2.27
SD – standard deviation; FVC – forced vital capacity; FEV1 – forced expiratory volume in 1 second; FEF75 – forced expiratory 
flow at 75 % FVC
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and baseline and post-bronchodilator FEF75 (expressed as 
percentile) (p<0.05 for all, Table 4). In multivariate analysis, 
EBT
AUC
 correlated independently with age, BMI, number of 
cigarettes smoked a day, baseline EBT, and baseline FEF75 
(R2=0.39, p<0.001 for the model, Table 5).
DISCUSSION
The main result of our study in “healthy” smokers was 
the sensitivity and discriminative power of EBT
AUC
 as a 
measure of airway reaction to acute cigarette smoke 
exposure, that is, of individual susceptibility of the airways 
to cigarette smoke toxicity.
The individual pattern of EBT change from baseline to 
one hour after a smoked cigarette (EBT
AUC
) independently 
correlated with age, and inversely with BMI, baseline EBT, 
number of cigarettes smoked per day, and lung function 
(index representing small airways). Although on average 
EBT reached maximum and plateaued between 5 and 30 
min after smoking, this response was not uniform for all 
participants. In fact, there were two distinct responses, 
significantly associated with participants’ demographics, 
acute (cigarettes per day) and chronic cigarette smoke 
exposure (age, pack-years), and lung function. This was, 
however, visible only from regression analysis because this 
kind of analysis exhibits greater statistical power. These 
findings suggest that a specific combination of genetic and 
epigenetic factors makes some individuals more prone to 
the adverse effects of cigarette smoke. The integrated 
expression of such a trait (cigarette smoke sensitivity 
phenotype) could be identified by assessing the change in 
EBT after smoking a cigarette (a cigarette challenge test). 
These findings also support our earlier ones in smokers 
at risk of developing COPD (4), in whom the rise in EBT 
from baseline to minute 5 after smoking turned out to be a 
significant predictor of newly developed COPD over two 
years of follow-up (4).
Tobacco smoke is a complex mixture of more than 4000 
compounds, most of which toxic, and is considered the 
major cause of COPD (11). According to Tuder et al. (12), 
cigarette smoke damages lung tissue in three stages: 1) 
initial tissue damage, 2) injury progression, and 3) 
propagation of cell damage (12). In the initial stage, tobacco 
smoke damages the cells of the alveolar septum through 
oxidative stress, apoptosis, and inflammation. In the second 
stage, continued exposure causes destruction of the alveolar 
walls and the development of emphysema. In the final stage, 
already damaged tissue causes its own destruction by 
activating signalling pathways which amplify the reuptake 
of pro-inflammatory cells and the expression of chemokines 
and cytokines (12).
Changes in EBT in this study seem to be associated with 
changes in vascularity (vasodilation or vasoconstriction). 
Numerous studies have tried to elucidate the development 
of COPD, but gaps remain in our understanding of the role 
of the airway vasculature, most likely because it is 
methodologically difficult to measure bronchial blood flow 
(13). Although earlier research suggests that pulmonary 
circulation is the one responsible for heat exchange in the 
airways between air and mucosa (14–16), McFadden et al. 
(17) believe that it is submucosal bronchial circulation that 
controls the temperature of exhaled air and causes the 
airways to narrow. Still, it is not clear if increased or 
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Table 3 Changes in EBT after smoking a cigarette (n=55)
All (n=55) Increase in EBT(n=37)
Decrease in EBT
(n=18)
Mean SD Range Mean SD Mean SD
Baseline EBT (°C) 33.46 1.49 27.94 35.19 33.18 1.66 33.92 1.15
EBT 5 min after a cigarette (°C) 33.86 1.23 28.39 35.47 33.81 1.37 33.97 1.11
EBT 15 min after a cigarette (°C) 33.84 1.43 28.90 35.16 33.95 1.37 33.50 1.71
EBT 30 min after a cigarette (°C) 33.84 1.44 28.76 35.43 33.89 1.49 33.67 1.58
EBT 45 min after a cigarette (°C) 33.79 1.42 28.76 35.40 33.81 1.58 33.67 1.33
EBT 60 min after a cigarette (°C) 33.51 1.53 28.14 35.33 33.58 1.61 33.26 1.61
EBT
AUC 
(°Cmin) 18.83 44.15 -101.73 179.23 37.36 41.94 -17.59 23.64
EBT – exhaled breath temperature; SD – standard deviation; AUC – area under the curve




Baseline EBT -0.441 0.001
FEV1/FVC -0.370 0.005
PB FEV1/FVC -0.334 0.013
FEV1 (z-score) -0.268 0.048
FEV1 (% predicted) -0.272 0.044
FEV1/FVC (z-score) -0.343 0.010
FEV1/FVC (percentile) -0.339 0.011
FEF75 (percentile) -0.275 0.042
PB FEV1 (% predicted) -0.268 0.048
PB FEV1/FVC (z-score) -0.296 0.028
PB FEV1/FVC (percentile) -0.334 0.013
PB FEF75 (percentile) -0.269 0.047
EBT – exhaled breath temperature; AUC – area under the curve; 
SD – standard deviation; FVC – forced vital capacity; FEV1 – 
forced expiratory volume in 1 second; PB – post-bronchodilator; 
FEF75 – forced expiratory flow at 75 % FVC
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decreased vascularity is associated with the development 
of COPD. Two histological studies showed diminished 
bronchial vasculature in a COPD population (18, 19), which 
was later confirmed by more recent studies (20, 21). On the 
other hand, based on the presence of chronic inflammation 
of the airways, a vascular proliferation could be expected, 
at least in some COPD phenotypes (22).
The inverse association with the number of cigarettes 
per day found in our study could point to two distinct 
mechanisms: 1) lower intrinsic reactivity, or 2) too short 
washout time from the last smoked cigarette in participants 
with higher cumulative daily exposure (23). The second 
mechanism is supported by the inverse association of 
baseline EBT with EBT
AUC
. Higher baseline EBT is 
associated with lower reactivity to repeated acute exposure 
to cigarette smoke or an already present level of inflammation 
and higher vascularity like in other inflammatory disorders 
of the airways (23–25). Our participants, however, did not 
show any pathology suggesting COPD. Lower EBT and 
EBT dynamics in patients with COPD can suggest lower 
heat exchange between air and airway mucosa because it 
is obstructed by hypersecretion of mucus and/or reduced 
vascularity as a consequence of morphological changes of 
the blood vessels (26).
The finding of significant inverse association between 
EBT
AUC
 and BMI in our participants may be owed to 
increased arterial stiffness found in obese population and 
therefore lower vascular reactivity (27).
Hogg et al. (28) reported contribution of the small 
airways to the total airway resistance in normal lungs, but 
also a four to forty-fold increase in small airway resistance 
in patients with emphysema. Several studies have confirmed 
that pathological changes in the small airways do not 
necessarily entail spirometric abnormalities consistent with 
COPD diagnosis, so these pathological changes are also 
known as the “silent zone” of the lungs (29, 30). Although 
mid-expiratory flow rates have been used to detect small 
airway dysfunction, they were not used for follow up 
because of a high degree of variability, which is why little 
has been known about the role of small airway dysfunction 
in the development of COPD until quite recently (31, 32). 
The ability to distinguish between the small airway damage 
and emphysema has been improved by the recent 
development of parametric response mapping, which allows 
information from all lung voxels in an inspiratory multiple 
detector CT scan to be assigned to voxels present on an 
expiratory scan, making it possible to identify parts of the 
lungs with functional small airway disease (33). Boes et al. 
(34) used parametric response mapping analysis to monitor 
the progression of functional small airway disease and 
emphysema over a year and concluded that it was a 
transitional stage between normal lung and emphysema. 
Our results show inverse association between EBT
AUC
 and 
the lung function parameter representing small airway 
dysfunction (FEF75), which suggests that EBTAUC could 
serve as a non-invasive marker of early pathological 
changes in smokers.
The limitations of our study lie in a relatively small 
sample, cross-sectional design of the study, and the use of 
spirometry to measure lung function parameters. However, 
the protocol using EBT
AUC
 showed to be highly reproducible 
and in line with other research of early changes in COPD, 
including our own follow-up study (4).
Our current findings suggest that the dynamics of EBT 
after smoking a cigarette could be associated with bronchial 
vasculature and small airway dysfunction, which 
corroborates the results of our previous study from a 
different perspective and supports that EBT has a potential 
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Presječna studija dinamike temperature izdaha nakon popušene cigarete i njezina povezanost s promjenama 
plućne funkcije u pušača prediktivnima za rizik od KOPB-a 
Temperatura izdaha (EBT) biomarker je upale i vaskularizacije dišnih putova za koji je utvrđeno da može predvidjeti 
nastanak KOPB-a. Cilj ove presječne studije bio je procijeniti potencijal EBT-a u identifikaciji “zdravih” pušača čiji su 
dišni putovi osjetljivi na toksični učinak duhanskoga dima uz rizik od nastanka KOPB-a. Taj se cilj planirao postići 
utvrđivanjem povezanosti dinamike EBT-a nakon popušene cigarete s demografskim karakteristikama (dob, spol, pušačka 
navika) i plućnom funkcijom ispitanika. U ispitivanje je bilo uključeno 55 aktivnih pušača obaju spolova u dobi od 29 
do 62 godine, čiji je medijan izloženosti duhanskom dimu bio 15 (10 – 71,8) pušačkih godina (pack-years). EBT je mjeren 
na početku te 5, 15, 30, 45 i 60 minuta nakon popušene cigarete. Plućnu funkciju mjerili smo spirometrijski, uz susljedni 
bronhodilatacijski test. Za analizu dinamike EBT-a koristili smo se analizom varijance te smo izračunali površinu ispod 




 upotrijebili kao zavisnu varijablu. Multivarijatna regresijska 
analiza korištena je za utvrđivanje povezanosti EBT
AUC
 s karakteristikama ispitanika, posebice s plućnom funkcijom. 
Prosječni (±SD) izmjereni početni EBT bio je 33,42±1,50 °C, a najveće značajno izmjereno povećanje zabilježeno je 5 
minuta nakon popušene cigarete (33,84 (1,25) °C, p=0,003). Bilo je potrebno 60 minuta kako bi se EBT vratio na početnu 
vrijednost. Utvrđena je značajna ponovljivost EBT
AUC
 (ICC=0,85, p<0,001). Ispitivanjem je utvrđeno je da je EBT
AUC
 
značajno nezavisno povezan s dobi, indeksom tjelesne mase, brojem popušenih cigareta dnevno, početnim EBT-om te s 
početnim FEF75 (R
2=0,39, p<0,001 za model). Rezultati ove studije sugeriraju da EBT nakon popušene cigarete može 
biti koristan kao rani prediktor rizika od promjena koje su povezane s kroničnom izloženosti duhanskom dimu.
KJUČNE RIJEČI: temperatura izdaha; pušenje cigareta; rizik od KOPB-a; disfunkcija malih dišnih putova; toksičnost 
duhanskoga dima
